Status:
COMPLETED
Comparison of IV Nalbuphine Versus Ibuprofen for Postoperative Pain Control in Cesarean Section
Lead Sponsor:
Muhammad Aamir Latif
Conditions:
Pain Management
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The local data is insufficient to directly compare IV nalbuphine versus ibuprofen among people in this region. The findings of this study would add to the existing data and would be helpful for health...
Eligibility Criteria
Inclusion
- Parturient females
- Aged between 18-45 years
- Gestational age above 32 weeks
- ASA class I to II
- Anticipated hospital stay for at least 24 hours
Exclusion
- Known allergy to the drugs being evaluated in this study
- Renal and/or hepatic impairment (as per medical record)
- History of bronchial asthma or history or risk of intracranial hemorrhage (as per medical record)
- Low platelets count (\<70000) or with bleeding diathesis
- BMI above 30 kg/m2
Key Trial Info
Start Date :
March 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06594224
Start Date
March 1 2024
End Date
August 31 2024
Last Update
September 19 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Nishtar Hospital
Multan, Punjab Province, Pakistan, 66000
2
Nishtar Medical University
Multan, Punjab Province, Pakistan, 66000